Welcome
The Chapel Hill Project is a non-profit organization created to advance the development of cell and gene therapies for orphan diseases through increased scientific collaboration. The Project's main goal is to facilitate the development of therapeutics for life threatening and other burdensome diseases for which no currently viable treatment option exists. By providing access to technology, scientific and clinical trials expertise and funding, the organization aims to aid in translating science from the laboratory to the clinic.
The Chapel Hill Project was formed by Asklepios BioPharmaceutical, Inc. ("AskBio") (www.askbio.com) in response to the scientific community's request to make its technology accessible to researchers for use in orphan drug development without the payment of any up-front costs. The Project is hopeful that other companies will contribute use of their cell- and gene-based technologies to this effort.
The Chapel Hill Project will be funded primarily through government and foundational grants and through charitable contributions from interested supporters.
